Bainian Yihao

About:

Centennial Nickname is positioned in the transformation of biomedical innovations and new drug research

Top Investors: DT Capital Partners, Chengdu Tianfu International Bio-Town Investment & Development, Canton Venture Capital, PKU V-Ming Investment

Description:

Established in 2017, the 100-year nickname is positioned in the transformation of biomedical innovations and new drug research and development institutions, mainly for the development of new drugs such as CAR-T cell therapy and tumor vaccines, such as immunotherapy, gene therapy, stem cell therapy and small molecule targeted drugs. .